CytomX Therapeutics (CTMX) Return on Equity [ROE] (2015 - 2026)
CytomX Therapeutics (CTMX) posted Return on Equity [ROE] of -25.61% for Q2 2026, down 91.81 percentage points from 66.20% a year earlier but up 2.62 percentage points from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, CytomX Therapeutics' Return on Equity [ROE] came in at -35.25%.
- Annual Return on Equity [ROE] shows a five-year change of +697.31 percentage points (FY2020 to FY2025).
- Quarterly Return on Equity [ROE] has run from a low of -773.16% in Q4 2021 to a high of 338.33% in Q1 2025 over five years.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -28.23% (Q1 2026), -16.83% (Q4 2025) and 24.65% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | CytomX Therapeutics | 431.65 Mn | -730.37 Mn | - | -29.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -29.28% |
| Jun 30, 2026 | -25.71% |
| Mar 31, 2026 | -28.22% |
| Dec 31, 2025 | -16.83% |
| Sep 30, 2025 | 24.77% |
| Jun 30, 2025 | 66.35% |
| Mar 31, 2025 | 338.96% |
| Dec 31, 2021 | -559.20% |
| Sep 30, 2021 | -162.60% |
| Jun 30, 2021 | -92.53% |
| Mar 31, 2021 | -167.42% |
| Dec 31, 2020 | -178.54% |
| Sep 30, 2020 | -106.23% |
| Jun 30, 2020 | -102.33% |
| Mar 31, 2020 | -165.11% |
| Dec 31, 2019 | -189.79% |
| Sep 30, 2019 | -107.51% |
| Jun 30, 2019 | -87.79% |
| Mar 31, 2019 | -64.19% |
| Dec 31, 2018 | -57.65% |
API Access
CytomX Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();